143.0000.56% ( -0.800 )
Delay Closed: Nov 17, 16:08:13Valuation
Current ValuationThe current P/E ratio is 65.05, within the reasonable range, cheaper than 64.5% of the time in the past 1 years, and the industry ranks 31/53, the industry Median 6.96.
65.05xP/E
HK$143.00Stock price
HK$2.20Earnings per share
65.05xP/E
Stock priceHK$143.00Earnings per shareHK$2.20
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 70.97x
- Typical range
- 61.26x–82.00x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.96x
017345168
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.96x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
02637HKHAIXI PHARMA | 65.05x | 6.78% | HK$11.26B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
